Compare Abbott India with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WOCKHARDT - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WOCKHARDT ABBOTT INDIA/
WOCKHARDT
 
P/E (TTM) x 51.0 -14.8 - View Chart
P/BV x 13.3 1.2 1,155.5% View Chart
Dividend Yield % 0.5 0.0 15,425.3%  

Financials

 ABBOTT INDIA   WOCKHARDT
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
WOCKHARDT
Mar-18
ABBOTT INDIA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs8,8341,012 872.9%   
Low Rs5,458532 1,026.8%   
Sales per share (Unadj.) Rs1,731.1355.9 486.5%  
Earnings per share (Unadj.) Rs211.9-60.3 -351.6%  
Cash flow per share (Unadj.) Rs219.9-46.8 -470.2%  
Dividends per share (Unadj.) Rs65.000.01 650,000.0%  
Dividend yield (eoy) %0.90 70,200.3%  
Book value per share (Unadj.) Rs945.2257.8 366.6%  
Shares outstanding (eoy) m21.25110.63 19.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.2 190.3%   
Avg P/E ratio x33.7-12.8 -263.4%  
P/CF ratio (eoy) x32.5-16.5 -196.9%  
Price / Book Value ratio x7.63.0 252.5%  
Dividend payout %30.70 -184,882.9%   
Avg Mkt Cap Rs m151,84885,379 177.9%   
No. of employees `0003.56.3 55.7%   
Total wages/salary Rs m4,3569,371 46.5%   
Avg. sales/employee Rs Th10,555.56,295.0 167.7%   
Avg. wages/employee Rs Th1,249.91,498.3 83.4%   
Avg. net profit/employee Rs Th1,292.2-1,066.3 -121.2%   
INCOME DATA
Net Sales Rs m36,78639,369 93.4%  
Other income Rs m1,1331,202 94.2%   
Total revenues Rs m37,91940,571 93.5%   
Gross profit Rs m6,04718 33,045.4%  
Depreciation Rs m1691,495 11.3%   
Interest Rs m232,555 0.9%   
Profit before tax Rs m6,989-2,830 -247.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m2,485257 967.0%   
Profit after tax Rs m4,503-6,669 -67.5%  
Gross profit margin %16.40 35,365.7%  
Effective tax rate %35.6-9.1 -391.5%   
Net profit margin %12.2-16.9 -72.3%  
BALANCE SHEET DATA
Current assets Rs m27,61033,796 81.7%   
Current liabilities Rs m8,56926,917 31.8%   
Net working cap to sales %51.817.5 296.2%  
Current ratio x3.21.3 256.6%  
Inventory Days Days6079 75.9%  
Debtors Days Days2789 30.7%  
Net fixed assets Rs m1,05739,664 2.7%   
Share capital Rs m213553 38.4%   
"Free" reserves Rs m19,87327,968 71.1%   
Net worth Rs m20,08628,522 70.4%   
Long term debt Rs m021,731 0.0%   
Total assets Rs m29,40981,620 36.0%  
Interest coverage x311.6-0.1 -289,809.6%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x1.30.5 259.3%   
Return on assets %15.4-5.0 -305.3%  
Return on equity %22.4-23.4 -95.9%  
Return on capital %34.9-7.7 -454.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3699,807 3.8%   
Fx outflow Rs m4,9181,789 275.0%   
Net fx Rs m-4,5498,019 -56.7%   
CASH FLOW
From Operations Rs m4,991684 729.3%  
From Investments Rs m-2,5706,302 -40.8%  
From Financial Activity Rs m-1,428-7,695 18.6%  
Net Cashflow Rs m993-664 -149.6%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 2.3 343.5%  
FIIs % 0.1 7.7 1.3%  
ADR/GDR % 0.0 0.1 -  
Free float % 17.1 15.4 111.0%  
Shareholders   18,270 67,757 27.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  PFIZER  ALEMBIC PHARMA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Buzz on the Street: A Look at Stocks, Sectors and the Economy(Podcast)

The stock markets in India remained rangebound this week. Economic data releases and third quarter results announcements were the focus of the week.

Related Views on News

WOCKHARDT Surges by 5%; BSE HEALTHCARE Index Up 0.4% (Market Updates)

Jan 24, 2020 | Updated on Jan 24, 2020

WOCKHARDT share price has surged by 5% and its current market price is Rs 296. The BSE HEALTHCARE is up by 0.4%. The top gainers in the BSE HEALTHCARE Index is WOCKHARDT (up 5.2%). The top losers are J.B.CHEMICALS and LAURUS LABS LTD (down 0.1%).

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 24, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - IPCA LABS COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS